These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 22892478)
1. Modularized Smad-regulated TGFβ signaling pathway. Li Y; Wang M; Carra C; Cucinotta FA Math Biosci; 2012 Dec; 240(2):187-200. PubMed ID: 22892478 [TBL] [Abstract][Full Text] [Related]
2. SMURF2 and SMAD7 induce SARA degradation via the proteasome. Wojtowicz S; Lee S; Chan E; Ng E; Campbell CI; Di Guglielmo GM Cell Signal; 2020 Aug; 72():109627. PubMed ID: 32283253 [TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of Smad2 is required for enhancement of TGFbeta/Smad signaling by TGFbeta inducible early gene. Johnsen SA; Subramaniam M; Katagiri T; Janknecht R; Spelsberg TC J Cell Biochem; 2002; 87(2):233-41. PubMed ID: 12244575 [TBL] [Abstract][Full Text] [Related]
4. Downregulation of SMAD2, 4 and 6 mRNA and TGFbeta receptor I mRNA in lesional and non-lesional psoriatic skin. Yu H; Mrowietz U; Seifert O Acta Derm Venereol; 2009; 89(4):351-6. PubMed ID: 19688145 [TBL] [Abstract][Full Text] [Related]
10. A phosphatase controls the fate of receptor-regulated Smads. Schilling SH; Datto MB; Wang XF Cell; 2006 Jun; 125(5):838-40. PubMed ID: 16751094 [TBL] [Abstract][Full Text] [Related]
11. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts. Mori Y; Chen SJ; Varga J Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691 [TBL] [Abstract][Full Text] [Related]
12. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer. Riesco-Eizaguirre G; Rodríguez I; De la Vieja A; Costamagna E; Carrasco N; Nistal M; Santisteban P Cancer Res; 2009 Nov; 69(21):8317-25. PubMed ID: 19861538 [TBL] [Abstract][Full Text] [Related]
13. PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling. Lin X; Duan X; Liang YY; Su Y; Wrighton KH; Long J; Hu M; Davis CM; Wang J; Brunicardi FC; Shi Y; Chen YG; Meng A; Feng XH Cell; 2006 Jun; 125(5):915-28. PubMed ID: 16751101 [TBL] [Abstract][Full Text] [Related]
14. Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. Goumans MJ; Mummery C Int J Dev Biol; 2000 Apr; 44(3):253-65. PubMed ID: 10853822 [TBL] [Abstract][Full Text] [Related]
16. Expression of transforming growth factor-beta (TGFbeta) and the TGFbeta signalling molecule SMAD-2P in spontaneous and instability-induced osteoarthritis: role in cartilage degradation, chondrogenesis and osteophyte formation. Blaney Davidson EN; Vitters EL; van der Kraan PM; van den Berg WB Ann Rheum Dis; 2006 Nov; 65(11):1414-21. PubMed ID: 16439443 [TBL] [Abstract][Full Text] [Related]
17. A novel dominant negative Smad2 mutation in a TGFbeta resistant human carcinoma cell line. Tsang KJ; Tsang D; Brown TN; Crowe DL Anticancer Res; 2002; 22(1A):13-9. PubMed ID: 12017275 [TBL] [Abstract][Full Text] [Related]
18. Rapamycin induces the TGFbeta1/Smad signaling cascade in renal mesangial cells upstream of mTOR. Osman B; Doller A; Akool el-S; Holdener M; Hintermann E; Pfeilschifter J; Eberhardt W Cell Signal; 2009 Dec; 21(12):1806-17. PubMed ID: 19666112 [TBL] [Abstract][Full Text] [Related]
19. Gremlin aggravates hyperglycemia-induced podocyte injury by a TGFβ/smad dependent signaling pathway. Li G; Li Y; Liu S; Shi Y; Chi Y; Liu G; Shan T J Cell Biochem; 2013 Sep; 114(9):2101-13. PubMed ID: 23553804 [TBL] [Abstract][Full Text] [Related]
20. Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2. Muro-Cacho CA; Rosario-Ortiz K; Livingston S; Muñoz-Antonia T Clin Cancer Res; 2001 Jun; 7(6):1618-26. PubMed ID: 11410498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]